A perspective on new beta-lactam antibiotics in pediatric patients.
作者信息
Nelson J D
出版信息
Bull N Y Acad Med. 1984 May;60(4):374-9.
Abstract
摘要
相似文献
1
A perspective on new beta-lactam antibiotics in pediatric patients.儿科患者新型β-内酰胺类抗生素的前景
Bull N Y Acad Med. 1984 May;60(4):374-9.
2
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.新型广谱β-内酰胺类和氟喹诺酮类抗生素在儿童中的作用。
Adv Pediatr Infect Dis. 1996;12:71-108.
3
[Prospects of antibiotic treatment in pediatric field].
Nihon Rinsho. 1981 Jan;39(1):72-9.
4
Practical use of penicillin, cephalosporin and aminoglycoside antibiotics.青霉素、头孢菌素和氨基糖苷类抗生素的实际应用。
Calif Med. 1972 Oct;117(4):17-27.
5
Antibacterial agents in pediatrics.儿科抗菌药物
Infect Dis Clin North Am. 1995 Sep;9(3):561-74.
6
[Antibiotics used for infections of central nervous system (suthor's transl)].用于中枢神经系统感染的抗生素（作者译）
No Shinkei Geka. 1977 Aug;5(9):909-18.
7
[Clinical experience with azlocillin].[阿洛西林的临床经验]
Med Welt. 1979 Nov 23;30(47):1790-3.
8
The new cephalosporins and penicillins.
Compr Ther. 1982 Feb;8(2):26-31.
9
American Academy of Pediatrics Committee on Infectious Diseases: Treatment of bacterial meningitis.美国儿科学会传染病委员会：细菌性脑膜炎的治疗
Pediatrics. 1988 Jun;81(6):904-7.
10
Guidelines issued on treatment of pediatric bacterial meningitis.
Clin Pharm. 1988 Sep;7(9):638.
本文引用的文献
1
Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.氨苄西林和氯霉素对B族链球菌脑膜分离株的拮抗作用。
Antimicrob Agents Chemother. 1981 Sep;20(3):281-5. doi: 10.1128/AAC.20.3.281.
2
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants.新型广谱氧杂β-内酰胺抗生素莫西拉坦在新生儿和婴儿中的临床评估。
J Pediatr. 1981 Jan;98(1):129-36. doi: 10.1016/s0022-3476(81)80559-8.
3
Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.三种抗生素治疗方案对囊性纤维化急性加重期的临床及细菌学反应：替卡西林-妥布霉素、阿洛西林-妥布霉素及阿洛西林-安慰剂。
J Infect Dis. 1983 Mar;147(3):559-67. doi: 10.1093/infdis/147.3.559.
4
Ceftriaxone pharmacokinetics in newborn infants.新生儿中头孢曲松的药代动力学
Antimicrob Agents Chemother. 1983 Feb;23(2):341-3. doi: 10.1128/AAC.23.2.341.
5
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.头孢曲松在患脑膜炎儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1983 Feb;23(2):191-4. doi: 10.1128/AAC.23.2.191.
6
Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.头孢曲松单剂量在患有中枢神经系统感染的儿科患者中的药代动力学。
J Pediatr. 1983 Jan;102(1):134-7. doi: 10.1016/s0022-3476(83)80311-4.
7
Pharmacokinetics of cefotaxime in newborn infants.头孢噻肟在新生儿中的药代动力学
Antimicrob Agents Chemother. 1982 Apr;21(4):683-4. doi: 10.1128/AAC.21.4.683.
8
Clinical pharmacology of cefotaxime in pediatric patients.头孢噻肟在儿科患者中的临床药理学
Antimicrob Agents Chemother. 1981 Oct;20(4):487-90. doi: 10.1128/AAC.20.4.487.
9
Single-dose pharmacokinetics of ceftriaxone in infants and young children.头孢曲松在婴幼儿中的单剂量药代动力学。
Antimicrob Agents Chemother. 1982 Feb;21(2):248-53. doi: 10.1128/AAC.21.2.248.
10
Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics.
J Pediatr. 1982 Mar;100(3):483-9. doi: 10.1016/s0022-3476(82)80466-6.
Zotero 插件